Carregant...
Whole Tumor Antigen Vaccines: Where Are We?
With its vast amount of uncharacterized and characterized T cell epitopes available for activating CD4(+) T helper and CD8(+) cytotoxic lymphocytes simultaneously, whole tumor antigen represents an attractive alternative source of antigens as compared to tumor-derived peptides and full-length recomb...
Guardat en:
| Publicat a: | Vaccines (Basel) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494356/ https://ncbi.nlm.nih.gov/pubmed/26343191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines3020344 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|